China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.55% | 4.78% | 5.50% | 7.61% | 10.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.55% | 4.78% | 5.50% | 7.61% | 10.85% |
| Cost of Revenue | 3.41% | 4.60% | 5.28% | 7.33% | 10.50% |
| Gross Profit | 4.30% | 5.73% | 6.71% | 9.13% | 12.78% |
| SG&A Expenses | 3.50% | 4.84% | 5.60% | 8.87% | 13.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.08% | 14.60% | 24.97% | 15.42% | 6.73% |
| Total Operating Expenses | 3.43% | 4.72% | 5.47% | 7.57% | 10.77% |
| Operating Income | 6.17% | 6.14% | 5.99% | 8.56% | 12.64% |
| Income Before Tax | 8.08% | 12.22% | 16.91% | 16.56% | 17.59% |
| Income Tax Expenses | 17.49% | 24.75% | 33.85% | 27.64% | 22.81% |
| Earnings from Continuing Operations | 5.54% | 9.01% | 12.85% | 13.82% | 16.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -26.14% | -23.77% | -20.93% | -21.38% | -23.30% |
| Net Income | -15.33% | -6.03% | 4.52% | 6.52% | 9.90% |
| EBIT | 6.17% | 6.14% | 5.99% | 8.56% | 12.64% |
| EBITDA | 5.56% | 7.34% | 9.06% | 11.46% | 15.32% |
| EPS Basic | -15.89% | -6.32% | 4.52% | 6.63% | 10.06% |
| Normalized Basic EPS | -18.63% | -2.30% | 18.60% | 21.80% | 26.36% |
| EPS Diluted | -16.19% | -7.06% | 3.26% | 5.89% | 9.70% |
| Normalized Diluted EPS | -18.63% | -2.30% | 18.60% | 21.80% | 26.36% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.01% | 0.49% | 0.00% | -0.02% | -0.05% |